Clinical trial
Clinical Study Of Schizophrenia in Both Men and Women
NCT00071747 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00071747 |
|---|---|
| Title | Clinical Study Of Schizophrenia in Both Men and Women |
| Official title | A Multi-Center, Double Blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine Versus Placebo As Add-On Therapy In Schizophrenia |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 176 |
| Start date | Aug 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Oct 31, 2003 |
| Last update posted | Sep 1, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: